334 filings
Page 9 of 17
8-K
kod7trf
10 Mar 20
Entry into a Material Definitive Agreement
12:00am
424B5
35r2nf14cbj7vv nhry7
10 Mar 20
Prospectus supplement for primary offering
12:00am
SEC STAFF
dwbxi
28 Feb 20
SEC staff action: Order
12:00am
8-K
pyb 5zv0u
27 Feb 20
T2 Biosystems Announces Fourth Quarter and Full Year 2019 Financial Results
12:10pm
SEC STAFF
wdsbsasyuc
6 Feb 20
SEC staff action: Order
12:00am
8-K
am1a57tlaue10eo
9 Jan 20
T2 Biosystems Announces Preliminary Fourth Quarter 2019 Financial Results
4:47pm
8-K
y6q3c 42eh
9 Jan 20
T2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer
4:46pm
8-K
nj4q2fe6
20 Nov 19
T2 Biosystems Announces Granting ofCE-Mark for T2Resistanceā¢ Panel
7:45am
NT 10-Q
bujtzdka rn
13 Nov 19
Notice of late quarterly filing
4:12pm
8-K
umqfmd4q fbl186jad
13 Nov 19
T2 Biosystems Reports Third Quarter 2019 Financial Highlights and Provides Corporate Update
3:19pm
SEC STAFF
xowotctot4guh
12 Sep 19
SEC staff action: Order
12:00am
8-K
vcj 26vzomgmpd5p
10 Sep 19
Entry into a Material Definitive Agreement
4:35pm
8-K
mlyn toeslkwbedergag
10 Sep 19
Entry into a Material Definitive Agreement
4:00pm
SEC STAFF
4v1sts2
6 Sep 19
SEC staff action: Order
12:00am
8-K
bbz46spdfc6cq99u
1 Aug 19
T2 Biosystems Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:32pm
8-K
g2vtm9
30 Jul 19
Entry into a Material Definitive Agreement
4:43pm
424B5
51joz6er tx
30 Jul 19
Prospectus supplement for primary offering
4:05pm